Navigation Links
Solos Endoscopy, Inc. Revenue Grows 34.8% for Third Quarter 2010

BOSTON, Oct. 27 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company generated revenues during the three months ended September 30, 2010 in the amount of $134,426 versus $99,710 for the three months ended September 30, 2009.  This was an increase of 34.8% for the three months during 2010 as compared to 2009.

Despite a down global economy, Solos has been able to increase its sales transactions due to consistent product orders from the Company's current customer base. Over the past twelve months, Solos has placed an emphasis on promoting and marketing its MammoView® product line to hospitals and cancer centers. Revenue for the third quarter was driven by sales from the MammoView® line as well as strong sales from its standard product line with increased orders for the Company's Vascular Clamp System.

"We completed another strong quarter of sales in 2010," stated Bob Segersten, President of Solos Endoscopy, Inc. "Year-to-date, we have delivered double-digit revenue growth in what continues to be a challenging economic environment."

The Company expects to post its full unaudited financial results for the three months ended September 30, 2010 on the Pink Sheets OTC Markets website within in the next forty-five days.

Throughout the remainder of 2010, the Company will continue its new product development for the MammoView® product line. In addition, Solos plans to achieve market expansion through its efforts to meet the requirements of the ISO 13485 standard and ultimately obtain the CE Mark and the permission to sell medical devices in the European Union and Canada.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at:

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

SOURCE Solos Endoscopy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Solos Endoscopy, Inc. Announces Results of 2010 Annual Shareholder Meeting
2. Solos Endoscopy, Inc. to Hold Annual Shareholder Meeting September 28, 2010
3. Solos Endoscopy, Inc. Develops Relay Lense Adapter System For MammoView® Product Line
4. Solos Endoscopy, Inc. Increases Revenues by 10 Percent for First Quarter 2010 as Compared to First Quarter 2009
5. Solos Endoscopy, Inc. Appoints Experienced CFO To Financial Leadership Amidst Growth
6. Solos Endoscopy, Inc. Granted U.S. Trademark for MammoView(R)
7. Solos Endoscopy, Inc. Set To Develop European Union Conforming CE Mark Technical File
8. Solos Endoscopy, Inc. Set To Develop New Polymer Dilator For MammoView(TM) System
9. Solos Endoscopy, Inc. Retains Expert Resource to Meet Requirements for ISO 13485 Quality Management System Initiative
10. Solos Endoscopy, Inc.s Breast Endoscopy System Featured in February Issue of General Surgery News
11. Solos Endoscopy, Inc. Set to Increase Business Through Sales and Product Development in 2010
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015   Royal Philips ... ScanWise Implant, the industry,s first MRI guided user interface ... scanning of patients with MR Conditional implants, such as ... the 2015 Radiological Society of North America Annual ... exams and supports diagnostic confidence of this growing patient ...
(Date:11/30/2015)... Nov. 30, 2015 Baxalta Incorporated ... leader dedicated to delivering transformative therapies to ... conditions, today announced the launch and first ... an extended circulating half-life recombinant factor VIII ... full-length ADVATE [Antihemophilic Factor (Recombinant)]. The treatment ...
(Date:11/30/2015)... PUNE, India , November 30, 2015 ... new market research report "Dental Lasers Market by Product (Soft ... Treatment, Periodontitis), End User (Hospitals, Clinics), and Geography - Global ... USD 224.7 Million by 2020, at a CAGR of 5.2% ... , Browse 140 market data Tables and 62 Figures spread ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... 2015 , ... Trevor and Taylor Crabb have unveiled an exciting new ... represent the United States. This hybrid crowdfunding campaign is designed to provide ... in addition to offering corporate sponsors with some great marketing deliverables with the brothers ...
(Date:11/30/2015)... ... November 30, 2015 , ... 1Heart ... Convention of the Federation of Philippine American Chambers of Commerce held from November ... , 1Heart Caregiver Services, as an active delegate from the Philippine American ...
(Date:11/30/2015)... ... November 30, 2015 , ... Stress, anxiety, illness, infection ... parent worry about possible tumors? , Heather Spader, MD, a new pediatric neurosurgeon at ... common, some signs might point to tumors. , “Bad headaches that don’t ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... driverless vehicle experience this summer, ushering in a new era of publicly accessible ... and electric shuttle, will continue to offer guests an up-close look at the ...
(Date:11/30/2015)... ... 30, 2015 , ... The presidential race normally deals with political issues of ... a national news story when Donald Trump makes disparaging remarks about Hillary Clinton’s hairstyle? ... than anyone wants to admit when it comes to how people are viewed by ...
Breaking Medicine News(10 mins):